Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.

Evolus said the Food and Drug Administration approved its injectable hyaluronic acid gels, known as Evolysse Form and Evolysse Smooth, in line with management expectations.

Former USPTO Director Kathi Vidal, now with Winston & Strawn, filed an amicus brief on Wednesday in an appeal to the Federal ...